Drug Profile
Respiratory syncytial virus vaccine oral - Vaxart
Alternative Names: RSV tablet vaccine - Vaxart; VXA-RSV-f oral vaccineLatest Information Update: 01 Nov 2023
Price :
$50
*
At a glance
- Originator Vaxart
- Class Respiratory syncytial virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Respiratory syncytial virus infections